Men who take once-daily aspirin have nearly double the risk of melanoma compared to men who are not exposed to daily aspirin, reports a new Northwestern Medicine study. Women, however, do not have an increased risk in this large patient population.

By age 65, one in three people will have a vision-impairing eye disease. Many sight-robbing conditions can be effectively treated if detected early enough, in many cases limiting or eliminating the damage to eyesight.

A new study indicates that sleep duration may influence the health-related quality of life experienced by individuals with chronic kidney disease (CKD).

As we spend greater time outdoors throughout the year, we place ourselves at risk for over-exposure and cumulative, toxic effects of the sun that can eventually promote the growth of skin cancers.

Antibody therapy developed at the Uniformed Services University of the Health Sciences as a treatment against the Nipah and Hendra viruses has led to an agreement announced between USU, the Henry M. Jackson Foundation for the Advancement of Military Medicine, Profectus BioSciences, Inc., and Emergent BioSolutions, Inc., for development of a human vaccine against the two deadly viruses. The USU-HJF Joint Technology Transfer Office licensed the technology, which is supported by the Coalition for Epidemic Preparedness Innovations.

The potential to promote antibiotic resistance in bacteria isn’t the only reason to avoid using antibiotics when possible. A new study reveals that antibiotics are also linked with an increased risk of developing kidney stones, with the greatest risk among children.